Cardinal Health Stock Forecast, Price & News

+0.37 (+0.73 %)
(As of 09/23/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume93,849 shs
Average Volume2.25 million shs
Market Capitalization$14.58 billion
P/E Ratio24.82
Dividend Yield3.84%
30 days | 90 days | 365 days | Advanced Chart
Receive CAH News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

Cardinal Health logo

About Cardinal Health

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical, and laboratory products. Cardinal Health was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

3.28 out of 5 stars

Medical Sector

4th out of 1,351 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 7 stocks

Analyst Opinion: 2.9Community Rank: 4.9Dividend Strength: 5.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cardinal Health (NYSE:CAH) Frequently Asked Questions

Is Cardinal Health a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cardinal Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View analyst ratings for Cardinal Health
or view top-rated stocks.

What stocks does MarketBeat like better than Cardinal Health?

Wall Street analysts have given Cardinal Health a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cardinal Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cardinal Health?

Cardinal Health saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 10,420,000 shares, an increase of 115.7% from the August 15th total of 4,830,000 shares. Based on an average daily trading volume, of 2,420,000 shares, the short-interest ratio is presently 4.3 days. Currently, 3.6% of the company's stock are sold short.
View Cardinal Health's Short Interest

When is Cardinal Health's next earnings date?

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Cardinal Health

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings data on Thursday, August, 5th. The company reported $0.77 EPS for the quarter, missing the Zacks' consensus estimate of $1.20 by $0.43. The business earned $42.59 billion during the quarter, compared to the consensus estimate of $40.25 billion. Cardinal Health had a trailing twelve-month return on equity of 93.70% and a net margin of 0.38%. The company's revenue was up 16.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.04 EPS.
View Cardinal Health's earnings history

How has Cardinal Health's stock been impacted by Coronavirus (COVID-19)?

Cardinal Health's stock was trading at $48.65 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CAH stock has increased by 5.9% and is now trading at $51.51.
View which stocks have been most impacted by COVID-19

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Thursday, August 5th. Stockholders of record on Friday, October 1st will be given a dividend of $0.491 per share on Friday, October 15th. This represents a $1.96 dividend on an annualized basis and a yield of 3.81%. The ex-dividend date of this dividend is Thursday, September 30th. This is a positive change from Cardinal Health's previous quarterly dividend of $0.49.
View Cardinal Health's dividend history

Is Cardinal Health a good dividend stock?

Cardinal Health pays an annual dividend of $1.96 per share and currently has a dividend yield of 3.84%. Cardinal Health has been increasing its dividend for 34 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Cardinal Health is 35.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 30.06% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.
View Cardinal Health's dividend history.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health issued an update on its FY 2022 earnings guidance on Thursday, September, 9th. The company provided EPS guidance of $5.600-$5.900 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.190. The company issued revenue guidance of -.

What price target have analysts set for CAH?

8 equities research analysts have issued 12 month price targets for Cardinal Health's stock. Their forecasts range from $50.00 to $68.00. On average, they expect Cardinal Health's stock price to reach $58.50 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price.
View analysts' price targets for Cardinal Health
or view top-rated stocks among Wall Street analysts.

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the following people:
  • Michael C. Kaufmann, Chief Executive Officer & Director
  • Jason M. Hollar, Chief Financial Officer
  • Brian S. Rice, Chief Information Officer & Executive VP
  • Jessica L. Mayer, Chief Compliance & Legal Officer
  • Michele A.M. Holcomb, EVP, Chief Strategy & Business Development Officer

What is Mike Kaufmann's approval rating as Cardinal Health's CEO?

357 employees have rated Cardinal Health CEO Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among Cardinal Health's employees.

Who are some of Cardinal Health's key competitors?

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Who are Cardinal Health's major shareholders?

Cardinal Health's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (12.32%), BlackRock Inc. (9.07%), State Street Corp (5.96%), Price T Rowe Associates Inc. MD (4.48%), Macquarie Group Ltd. (3.58%) and FMR LLC (2.54%).
View institutional ownership trends for Cardinal Health

Which institutional investors are selling Cardinal Health stock?

CAH stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Bank of New York Mellon Corp, Macquarie Group Ltd., AQR Capital Management LLC, Lazard Asset Management LLC, Alyeska Investment Group L.P., Royal Bank of Canada, and Bank of Nova Scotia.
View insider buying and selling activity for Cardinal Health
or view top insider-selling stocks.

Which institutional investors are buying Cardinal Health stock?

CAH stock was bought by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, FMR LLC, American Century Companies Inc., Amundi, Morgan Stanley, Morgan Stanley, First Trust Advisors LP, and Schonfeld Strategic Advisors LLC.
View insider buying and selling activity for Cardinal Health
or or view top insider-buying stocks.

How do I buy shares of Cardinal Health?

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardinal Health's stock price today?

One share of CAH stock can currently be purchased for approximately $51.51.

How much money does Cardinal Health make?

Cardinal Health has a market capitalization of $14.62 billion and generates $162.47 billion in revenue each year. The company earns $611 million in net income (profit) each year or $5.57 on an earnings per share basis.

How many employees does Cardinal Health have?

Cardinal Health employs 47,300 workers across the globe.

Does Cardinal Health have any subsidiaries?

The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Access Closure Inc., Aero-Med Ltd., Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, AssuraMed Inc., Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 Inc., Cardinal Health 104 LP, Cardinal Health 105 Inc., Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 Inc., Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Medical Products India Private Limited, Cardinal Health Mexico 244 S. de R.L. de C.V., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health Norway AS, Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Poland Spółlka z ograniczonąa odpowiedzialnośsciąa, Cardinal Health Portugal 513 Unipessoal Lda., Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Specialty Pharmacy LLC, Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Cashel Company Unlimited, Cordis Corporation, Cornerstone Partners G.P.O. L.P., Covidien Manufacturing Solutions S.A., Curaspan Health Group Inc., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies Inc., Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR Italia S.r.l., KPR Switzerland Sales Gmbh, KPR U.S. LLC, Kendall Patient Recovery BVBA, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Limited Liability Company "Cardinal Health Russia", Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Medtronic - Patient Monitoring & Recovery, Mirixa Corporation, NaviHealth, Nippon Covidien Ltd., One Cloverleaf LLC, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Post-Acute Care Center for Research LLC, Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R Cubed Inc., R.P. Scherer Corporation, RGH Enterprises Inc., RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Tradex International Inc., Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, mscripts, mscripts LLC, and mscripts Systems India Private Limited.

When was Cardinal Health founded?

Cardinal Health was founded in 1971.

What is Cardinal Health's official website?

The official website for Cardinal Health is www.cardinalhealth.com.

Where are Cardinal Health's headquarters?

Cardinal Health is headquartered at 7000 CARDINAL PLACE, DUBLIN OH, 43017.

How can I contact Cardinal Health?

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at (614) 757-5000 or via email at [email protected].

This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.